Phillip J. Koo, MD | Authors


EP. 2B: New Horizons in Nuclear Medicine for Prostate Cancer

September 30, 2021

In an interview with Targeted Oncology™, Phillip J. Koo, MD, discusses both the role of novel PSMA tracers in prostate cancer imaging and the promise that theranostics, including LuPSMA, hold for prostate cancer therapy.